Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)
To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The study of the first degree, both sides in some of the aortic branch group, the effect and/or cause of systemic arterial hypertension compared to normotension. According to the theory of systemic arterial hypertension, the arterial resistance and high blood volume flow causing systemic arterial hypertension, the cause of arterial resistance and high blood volume flow evaluation may trace back to the possible actual cause of systemic arterial hypertension by backward investigation. Despite the fact that target organ damage is the crucial maneuver of hypertension evaluation, both sides of the common carotid artery, renal artery, and femoral artery may cause systemic arterial hypertension and may imply that feasible to predict the end organ of stroke, ESRD, and amputated-type arterial occlusion, respectively.
This study belongs to 2 questions
- Can the main aortic branch be evidence of a cause of systemic arterial hypertension following high resistance and/or high fluid flow by theory?
- Can the main aortic branch be a marker of evidence of endpoint organ damage?
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Nathaphong Dejthida, Medical Degree
- Telefonnummer: +66819220662
- E-post: bnnatto@gmail.com
Studieorter
-
-
Bangkok
-
Vadhana, Bangkok, Thailand, 10110
- Invstigation center
-
Kontakt:
- Nathaphong Dejthida, Medical Degree
- Telefonnummer: 0819220662
- E-post: bnnatto@gmail.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Hypertensive patient who underwent the radiographic measurement of structure and function of carotid artery, renal artery or femoral artery
Beskrivning
Inclusion Criteria:
-
Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
-
Imaging evidence of at least 1 list of
- Common carotid artery
- Renal artery
- Femoral artery
Exclusion Criteria:
- Fatal pathology and imaging
- Pediatric or pregnant participants
- Small vessel angiogram
- Intravascular endoscopy
- Intra-operative estimation
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: RETROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Common Carotid Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Common Carotid Artery. |
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s) |
|
Renal Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Renal Artery. |
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s) |
|
Femoral Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Femoral Artery. |
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s) |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.
Tidsram: 1 years
|
Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients. |
1 years
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Common Carotid Artery Function
Tidsram: 1 year
|
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery |
1 year
|
|
Renal Artery Function
Tidsram: 1 year
|
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery |
1 year
|
|
Femoral Artery Function
Tidsram: 1 year
|
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery |
1 year
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
All-cause mortality outcomes
Tidsram: 1 year
|
Incidence of mortality rate (case per 1,000 person-year) of hypertensive participants were underwent measurement the diameter one side of one of common carotid artery and/or renal artery and/or femoral artery |
1 year
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- NathaphongD
- PROSPERO (Annan identifierare: CRD420261464383)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .